CongressBuys

Rep. Byron Donalds sold Regeneron Pharmaceuticals (REGN)

Rep. Byron Donalds (R-FL-19) · $1K–$15K · traded Apr 10, 2025

Transaction
Sold
Amount
$1K–$15K
Owner
Not stated
Traded
Apr 10, 2025
Disclosed
May 24, 2025
Days to disclose
44
Asset type
Stock
As filed
Regeneron Pharmaceuticals, Inc. - Common Stock
Industry
Biotechnology · Healthcare

Other trades in this filing

  • Bought Amphenol APH

    $1K–$15K · Traded Apr 10, 2025 · disclosed May 24, 2025

  • Sold Nu Holdings NU

    $1K–$15K · Traded Apr 10, 2025 · disclosed May 24, 2025

    Committee overlap: Financial Services
  • Bought Visa V

    $1K–$15K · Traded Apr 10, 2025 · disclosed May 24, 2025

    Committee overlap: Financial Services
  • Bought Amphenol APH

    $1K–$15K · Traded Apr 10, 2025 · disclosed May 24, 2025 · Spouse

  • Sold Regeneron Pharmaceuticals REGN

    $1K–$15K · Traded Apr 10, 2025 · disclosed May 24, 2025 · Spouse

  • Bought Visa V

    $1K–$15K · Traded Apr 10, 2025 · disclosed May 24, 2025 · Spouse

    Committee overlap: Financial Services
  • Sold Nu Holdings NU

    $1K–$15K · Traded Apr 10, 2025 · disclosed May 24, 2025 · Spouse

    Committee overlap: Financial Services

Recent Congress trades in REGN

From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.